ArticlePharmacological research2024

Effects of SGLT2 inhibition via empagliflozin on cognitive and physical impairment in frail diabetic elders with chronic kidney disease.

Pasquale Mone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.